US › Healthcare

Accendra Health Inc (ACH)

US · Healthcare · Medical Distribution

$1.03-3.74%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$613.2M

Revenue YoY

-10.1%

Net profit

$-89.1M

EPS

$-0.19

EPS estimate

$-0.13

Net margin

-14.5%

EPS came in at -0.19 against a street estimate of -0.13 — a miss of 46.2%.

Key statistics

Market cap

$83.1M

Forward P/E

2.9

P/B

1.07

Book value

$-7.16

EPS (TTM)

$-1.45

52-week high

$5.69

52-week low

$0.93

50-day MA

$2.28

200-day MA

$2.61

Beta

1.52

Analyst view

with an average price target of $1.51.

Shareholding

Insiders

7.68%

Institutions

84.23%

Largest institutional holders

Fund	Stake
Coliseum Capital Management LLC	17.04%
BlackRock Inc	6.81%
Charles Schwab Investment Management Inc	4.73%
Bank of America Corp	4.43%
Invenomic Capital Management, LP	4.38%
Vanguard Capital Management, LLC	4.27%
D. E. Shaw & Co LP	4.01%
Vanguard Portfolio Management, LLC	3.45%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Accendra Health Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.